Group: Neurobioquímica

Doctor by the Universidad de Salamanca with the thesis Translational steps towards the clinical application of tat-cx43266-283 for the treatment of glioblastoma egfr as a predictor and mediator of treatment response, and positive results in combination with tumor resection in a preclinical model 2024. Supervised by Dr. María Aránzazu Tabernero Urbieta.

Has been a member of...